| Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia M Kanda, H Matthaei, J Wu, SM Hong, J Yu, M Borges, RH Hruban, ... Gastroenterology 142 (4), 730-733. e9, 2012 | 546 | 2012 |
| ATM mutations in patients with hereditary pancreatic cancer NJ Roberts, Y Jiao, J Yu, L Kopelovich, GM Petersen, ML Bondy, ... Cancer discovery 2 (1), 41-46, 2012 | 432 | 2012 |
| MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance T Moriyama, K Ohuchida, K Mizumoto, J Yu, N Sato, T Nabae, S Takahata, ... Molecular cancer therapeutics 8 (5), 1067-1074, 2009 | 358 | 2009 |
| The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ... Nature 486 (7402), 266-270, 2012 | 285 | 2012 |
| MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls A Li, J Yu, H Kim, CL Wolfgang, MI Canto, RH Hruban, M Goggins Clinical cancer research 19 (13), 3600-3610, 2013 | 267 | 2013 |
| Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ... The Journal of pathology 233 (3), 217-227, 2014 | 257 | 2014 |
| MicroRNA alterations of pancreatic intraepithelial neoplasias J Yu, A Li, SM Hong, RH Hruban, M Goggins Clinical cancer research 18 (4), 981-992, 2012 | 231 | 2012 |
| MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation J Yu, K Ohuchida, K Mizumoto, N Sato, T Kayashima, H Fujita, K Nakata, ... Molecular cancer 9 (1), 1-10, 2010 | 212 | 2010 |
| Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma K Shindo, J Yu, M Suenaga, S Fesharakizadeh, C Cho, A Macgregor-Das, ... Journal of Clinical Oncology 35 (30), 3382, 2017 | 180 | 2017 |
| Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy H Fujita, K Ohuchida, K Mizumoto, S Itaba, T Ito, K Nakata, J Yu, ... Neoplasia 12 (10), 807-IN8, 2010 | 171 | 2010 |
| MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma N Ikenaga, K Ohuchida, K Mizumoto, J Yu, T Kayashima, H Sakai, H Fujita, ... Annals of surgical oncology 17 (12), 3120-3128, 2010 | 131 | 2010 |
| Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins Gut 64 (11), 1783-1789, 2015 | 122 | 2015 |
| MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion J Yu, K Ohuchida, K Mizumoto, H Fujita, K Nakata, M Tanaka Cancer biology & therapy 10 (8), 748-757, 2010 | 120 | 2010 |
| Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ... Annals of surgery 270 (2), 340, 2019 | 118 | 2019 |
| Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer S Ohhashi, K Ohuchida, K Mizumoto, H Fujita, T Egami, J Yu, H Toma, ... Anticancer research 28 (4B), 2205-2212, 2008 | 108 | 2008 |
| Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal … J Yu, Y Sadakari, K Shindo, M Suenaga, A Brant, JAN Almario, M Borges, ... Gut 66 (9), 1677-1687, 2017 | 102 | 2017 |
| α-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma H Fujita, K Ohuchida, K Mizumoto, K Nakata, J Yu, T Kayashima, L Cui, ... Pancreas 39 (8), 1254-1262, 2010 | 94 | 2010 |
| Tumor–stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells H Fujita, K Ohuchida, K Mizumoto, T Egami, K Miyoshi, T Moriyama, L Cui, ... Cancer science 100 (12), 2309-2317, 2009 | 87 | 2009 |
| Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ... Annals of surgery, 2019 | 85 | 2019 |
| Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas A Pea, J Yu, N Rezaee, C Luchini, J He, M Dal Molin, JF Griffin, H Fedor, ... Annals of surgery 266 (1), 133, 2017 | 79 | 2017 |
Michael GogginsJohns Hopkins UniversityVerified email at jhmi.edu
